![Erich Hunziker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erich Hunziker
Président chez NOVIMMUNE SA
Fortune : 33 M $ au 31/03/2025
Profil
Le Dr Erich Hunziker est président du conseil de surveillance de BB Biotech AG, président du conseil de surveillance de Discoveric AG, président du conseil de surveillance de discoveric bio alpha AG, président du conseil de surveillance de discoveric bio beta AG, président du conseil de surveillance de discoveric marina AG, président du conseil de surveillance d'Entsia International AG, président du conseil de surveillance de Light Chain Biosciences AG et président du conseil de surveillance de Novimmune SA. Il est membre du conseil d'administration d'EngMab SARL, de l'International Institute for Management Development, de Lamkap Bio Alpha AG, de LamKap Bio beta AG, de LamKap Bio beta AG et de Lamkap Bio Gamma AG. Le Dr Hunziker a été précédemment employé en tant que directeur financier et des technologies de l'information par Roche Holding AG, directeur financier par F. Hoffmann-La Roche Ltd, directeur général par Diethelm Keller Holding AG, vice-président par Holcim Ltd, directeur financier par Roche Diagnostics GmbH, directeur financier par Corange Ltd, vice-président par Roche Holdings, Inc. et directeur financier par Roche Ventures. Il a également siégé au conseil d'administration de Chugai Pharmaceutical Co., Ltd, Genentech, Inc, AB2 Bio SA et Pharmaq Holding AS. Il a obtenu son doctorat à l'Institut fédéral suisse de technologie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BB BIOTECH AG 1,73% | 31/12/2023 | 957 884 ( 1,73% ) | 33 M $ | 31/03/2025 |
Dernières actualités sur Erich Hunziker
Postes actifs de Erich Hunziker
| Sociétés | Poste | Début |
|---|---|---|
| NOVIMMUNE SA | Président | - |
Discoveric Bio Gamma AG | Président | - |
discoveric bio beta AG | Président | - |
discoveric bio alpha AG | Président | - |
discoveric marina AG | Président | - |
Lamkap Bio Gamma AG | Président | - |
LamKap Bio beta AG
 LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Président | - |
Lamkap Bio Alpha AG | Président | - |
Discoveric AG | Président | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Erich Hunziker
| Sociétés | Poste | Fin |
|---|---|---|
| ░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Erich Hunziker
Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD. | Health Technology |
| BB BIOTECH AG | Finance |
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 23 |
|---|---|
Genentech, Inc.
 Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
EngMab SARL
 EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Corange Ltd.
 Corange Ltd. Pharmaceuticals: GenericHealth Technology Part of Roche Holding AG, Corange Ltd. is a Bermudian company that manufactures orthopedic and diagnostics equipment. The company is based in Hamilton, Bermuda. Corange was acquired by Roche Holding AG on May 01, 1997 for $10,930.22 million. | Health Technology |
Diethelm Keller Holding AG
 Diethelm Keller Holding AG Miscellaneous Commercial ServicesCommercial Services Diethelm Keller Holding Ltd. holding company with interest in providing brand management, marketing, logistics and travel services. The firm brands include EDAK, Koenig, Turmix, Zyliss, Wetrok, Delta and Gloster. The company is headquartered in Zurich, Switzerland. | Commercial Services |
Holcim Ltd. (Switzerland)
 Holcim Ltd. (Switzerland) Construction MaterialsNon-Energy Minerals Holcim Ltd. engages in the provision of building materials. It carries out its operations through the following product lines: Cement, Aggregates, and Other Construction Materials and Services. The Cement line provides wide range of cementations materials and also develops customized blends for special applications. The Aggregates line includes crushed stone, gravel and sand. The Other Construction Materials and Services line comprises ready-mix concrete, concrete products, asphalt, construction and paving, trading, and other products and services. The company was founded on February 15, 1912 and is headquartered in Zurich, Switzerland. | Non-Energy Minerals |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures (Roche Ventures) is a venture capital subsidiary of Roche Holding AG founded in 2002. The firm is headquartered in Basel, Switzerland. | Finance |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Roche Holdings, Inc.
 Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Health Technology |
Pharmaq Holding AS
 Pharmaq Holding AS Financial ConglomeratesFinance Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway. | Finance |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Entsia International AG | |
Discoveric AG | |
Lamkap Bio Alpha AG | |
LamKap Bio beta AG
LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Lamkap Bio Gamma AG | |
discoveric marina AG | |
discoveric bio alpha AG | |
discoveric bio beta AG | |
Discoveric Bio Gamma AG | |
Discoveric Marketplace AG |
